RET and cancer: A search for predicted nonsynonymous mutations in a set of 138 genes that are known to be mutated by single-base substitutions and indels in human cancers (Futreal et al., 2004) yielded heterozygous single-base substitutions in RET and FANCD2 that were not present in either of the two normal genomes that we sequenced.